<code id='4CC2801A37'></code><style id='4CC2801A37'></style>
    • <acronym id='4CC2801A37'></acronym>
      <center id='4CC2801A37'><center id='4CC2801A37'><tfoot id='4CC2801A37'></tfoot></center><abbr id='4CC2801A37'><dir id='4CC2801A37'><tfoot id='4CC2801A37'></tfoot><noframes id='4CC2801A37'>

    • <optgroup id='4CC2801A37'><strike id='4CC2801A37'><sup id='4CC2801A37'></sup></strike><code id='4CC2801A37'></code></optgroup>
        1. <b id='4CC2801A37'><label id='4CC2801A37'><select id='4CC2801A37'><dt id='4CC2801A37'><span id='4CC2801A37'></span></dt></select></label></b><u id='4CC2801A37'></u>
          <i id='4CC2801A37'><strike id='4CC2801A37'><tt id='4CC2801A37'><pre id='4CC2801A37'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:82
          The FDA building -- First Opinion coverage from STAT
          Adobe

          WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

          Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

          advertisement

          To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia
          Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

          FILE-RichardMoore,theChiefofBritain'sSecretIntelligenceService,alsoknownasMI6,answersquestionsafterg

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Biden administration sends mixed signals on US soldier who crossed into North Korea

          3:54SouthKoreansoldierspatrolwhilehikersvisittheDMZPeaceTrailinthedemilitarizedzoneinGoseong,SouthKo